All lobbying filings

CHATTEM, INC D/B/A OPELLA

Lobbying for CHATTEM, INC D/B/A OPELLA · Healthcare related to nonprescription drugs and dietary supplements.

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · New Jersey · House · Senate · $160,000.00 expenses · posted Oct 15, 2025

Official filing document

Bills named in this filing 3

HR 4273
Over-the-Counter Monograph Drug User Fee Amendments
S 2292
Over-the-Counter Monograph Drug User Fee Amendments
S 2529
A bill to increase the clarity and predictability of the process for developing applications for Rx-to-nonprescription …

Lobbying activity 2

Trade (domestic/foreign)

Tariffs

Health Issues

H.R.4273 - Over-the-Counter Monograph User Fee Amendments; S.2292 - Over-the-counter Monograph User Fee Amendments; S.2529 - The Streamlining Market Access for Therapeutics OTC Act.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.